NP Life Sciences Health Industry Group annual shareholders’ equity
2019
2020
2021
2022
2023
NP Life Sciences Health Industry Group Shareholders’ Equity Growth & History (ACAT)
NP Life Sciences Health Industry Group's shareholders’ equity was $16,381 for fiscal 2023.
View full NP Life Sciences Health Industry Group company overviewNP Life Sciences Health Industry Group annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $16,381 | −$2,935 | −15.19% |
| 2022 | 2022-12-31 | $19,316 | −$18,856 | −49.40% |
| 2021 | 2021-12-31 | $38,172 | −$65,677 | −63.24% |
| 2020 | 2020-12-31 | $103,849 | −$131,065 | −55.79% |
| 2019 | 2019-12-31 | $234,914 | — | — |
NP Life Sciences Health Industry Group quarterly shareholders’ equity
As of Dec 31, 2018
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.25
Q2.25
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2025 | 2025-06-30 | −$25,606 | — | — |
| Q1 2025 | 2025-03-31 | −$3,923 | — | — |
| Q4 2023 | 2023-12-31 | $16,381 | −$2,935 | −15.19% |
| Q3 2023 | 2023-09-30 | $31,736 | $29,018 | +1067.62% |
| Q2 2023 | 2023-06-30 | $67,111 | $58,953 | +722.64% |
| Q1 2023 | 2023-03-31 | $20,538 | $13,458 | +190.08% |
| Q4 2022 | 2022-12-31 | $19,316 | −$18,856 | −49.40% |
| Q3 2022 | 2022-09-30 | $2,718 | −$3,185 | −53.96% |
| Q2 2022 | 2022-06-30 | $8,158 | −$18,705 | −69.63% |
| Q1 2022 | 2022-03-31 | $7,080 | −$72,526 | −91.11% |
| Q4 2021 | 2021-12-31 | $38,172 | −$65,677 | −63.24% |
| Q3 2021 | 2021-09-30 | $5,903 | −$119,604 | −95.30% |
| Q2 2021 | 2021-06-30 | $26,863 | −$124,276 | −82.23% |
| Q1 2021 | 2021-03-31 | $79,606 | −$125,186 | −61.13% |
| Q4 2020 | 2020-12-31 | $103,849 | −$131,065 | −55.79% |
| Q3 2020 | 2020-09-30 | $125,507 | −$151,729 | −54.73% |
| Q2 2020 | 2020-06-30 | $151,139 | — | — |
| Q1 2020 | 2020-03-31 | $204,792 | — | — |
| Q4 2019 | 2019-12-31 | $234,914 | $255,599 | — |
| Q3 2019 | 2019-09-30 | $277,236 | — | — |
| As of Dec 31, 2018 | 2018-12-31 | −$20,685 | — | — |
NP Life Sciences Health Industry Group shareholders’ equity trends
Between the periods ended 2019-12-31 and 2023-12-31, NP Life Sciences Health Industry Group's shareholders’ equity decreased from $234,914 to $16,381, a change of −$218,533. The latest reported quarter, Q2 2025, shows −$25,606.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NP Life Sciences Health Industry Group source filings ↗